Skip to main content
SpringerLink
Log in

Encouraging Results of Low-Dose Etoposide in the Treatment of Early-Onset Hemophagocytic Syndrome Following Allogeneic Hematopoietic Stem Cell Transplantation

  • Letter to the Editor
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kawa K. Hemophagocytic syndrome -treatment strategies according to classification and scoring system. In: Education Program Book of the 67th Annual Meeting of the Japanese Society of Hematology and the 47th Annual Meeting of the Japanese Society of Clinical Hematology. Tokyo, Japan; 2005:72–75.

  2. Ishii E, Ohga S, Imashuku S, et al. Nationwide survey of hemophagocytic lymphohistiocytosis in Japan.Int J Hematol. 2007;86:58–65.

    Article  PubMed  Google Scholar 

  3. Levy J, Wodell RA, August CS, Bayever E. Adenovirus-related hemophagocytic syndrome after bone marrow transplantation.Bone Marrow Transplant. 1990;6:349–352.

    PubMed  CAS  Google Scholar 

  4. Sato M, Matsushima T, Takada S, et al. Fulminant, CMV-associated, haemophagocytic syndrome following unrelated bone marrow transplantation.Bone Marrow Transplant. 1998;22:1219–1222.

    Article  PubMed  CAS  Google Scholar 

  5. Ishikawa J, Maeda T, Miyazaki T, et al. Early onset of hemophagocytic syndrome following allogeneic bone marrow transplantation.Int J Hematol. 2000;72:243–246.

    PubMed  CAS  Google Scholar 

  6. Fukuno K, Tsurumi H, Yamada T, Oyama M, Moriwaki H. Graft failure due to hemophagocytic syndrome after autologous peripheral blood stem cell transplantation.Int J Hematol. 2001;73:262–265.

    Article  PubMed  CAS  Google Scholar 

  7. Abe Y, Choi I, Hara K, et al. Hemophagocytic syndrome: a rare complication of allogeneic nonmyeloablative hematopoietic stem cell transplantation.Bone Marrow Transplant. 2002;29:799–801.

    Article  PubMed  CAS  Google Scholar 

  8. Imashuku S, Kuriyama K, Teramura T, et al. Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. JClin Oncol. 2001;19:2665–2673.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Osaka Medical Center and Research Institute for Maternal and Child Health, 840 Murodo-cho Izumi City, Osaka, Japan

    Maho Koyama, Akihisa Sawada, Masahiro Yasui, Masami Inoue & Keisei Kawa

Authors
  1. Maho Koyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Akihisa Sawada
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Masahiro Yasui
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Masami Inoue
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Keisei Kawa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maho Koyama.

About this article

Cite this article

Koyama, M., Sawada, A., Yasui, M. et al. Encouraging Results of Low-Dose Etoposide in the Treatment of Early-Onset Hemophagocytic Syndrome Following Allogeneic Hematopoietic Stem Cell Transplantation. Int J Hematol 86, 466–467 (2007). https://doi.org/10.1007/BF02984009

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02984009

Keywords

Search

Navigation